STAT — Reporting from the frontiers of health and medicine
- Health Tech STAT Plus: New antidepressant study provides hints to Verily’s future
- Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
- First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
- Insurance STAT Plus: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
- Biotech STAT Plus: KKR veteran sets records with $3.9 billion health care fund
- First Opinion Unlocking the promise of learning from everyone with cancer
- Pharmalot STAT Plus: Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
- Health Tech STAT Plus: New antidepressant study provides hints to Verily’s future
- Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
- First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
- Insurance STAT Plus: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
- Biotech STAT Plus: KKR veteran sets records with $3.9 billion health care fund
- First Opinion Unlocking the promise of learning from everyone with cancer
- Pharmalot STAT Plus: Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
Exclusive analysis of biotech, pharma, and the life sciences
- Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
- First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
- Politics STAT Plus: Medicare may test policy of paying less for accelerated approval drugs
-
- First Opinion Disruptive science is leaping forward, not limping along
- Biotech STAT Plus: KKR veteran sets records with $3.9 billion health care fund
- Health Tech GoodRx leaked sensitive health information to Facebook and Google, FTC alleges
- Pharmalot STAT Plus: Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
- Health MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children
- Insurance STAT Plus: ‘Everybody has blood on their hands’: A decade-long battle over Medicare Advantage audits is coming to a head
